The BioDisruptors Podcast

Ep. 29 Inside the Plant Powered Pharmaceutical Factory

What if the factory of the future looks more like a greenhouse than a clean room full of steel tanks? In this episode, we explore a surprising shift in biotechnology where scientists use living plants to make vaccines, antibodies, and other critical medicines. You will learn why a humble tobacco relative has become one of the most important tools in modern biotech, how genes can be delivered into leaves in a matter of minutes, and why this approach could dramatically speed up responses to future pandemics and supply chain disruptions. Featured Article: Harnessing Transient Expression Systems with Plant Viral Vectors for the Production of Biopharmaceuticals in Nicotiana benthamiana (https://doi.org/10.3390/ijms26125510 [https://doi.org/10.3390/ijms26125510])

Ep. 28 Bursting the Bubble: The Hidden Threat to Bioprocessing

Foam is more than just a nuisance! In large-scale biomanufacturing, it is a multibillion-dollar risk. This episode explores how "foaming out" can jeopardize sterility and kill the cell cultures responsible for life-saving drugs. We examine the high-stakes trade-off between foam control, cell health, and productivity. We also look at the shift toward optical monitoring, a non-invasive technology that is replacing outdated sensors to ensure process stability and maximize yield. Featured Article: Measurement and Control of Foam Generation in a Mammalian Cell Culture (https://doi.org/10.1002/btpr.3450 [https://doi.org/10.1002/btpr.3450])

Ep. 27 Astronaut Food to mRNA: The Radical Evolution of Lyophilization

This week, we explore the critical yet often overlooked world of lyophilization, better known as freeze drying. While you might associate it with astronaut food, it is actually the backbone of the modern pharmaceutical supply chain, stabilizing everything from mRNA vaccines to life saving biologics. We break down how the industry is ditching inefficient, decades old batch processing for a revolutionary suspended vial continuous system. By suspending vials individually, manufacturers can eliminate the effect of uneven heating, ensuring every single dose experiences identical physics. Featured Article:  Mechanistic Modeling of Continuous Lyophilization for Biopharmaceutical Manufacturing (https://doi.org/10.1002/advs.202511693 [https://doi.org/10.1002/advs.202511693])

Ep. 26 DMSO in Cell Therapy: Separating Fact from Fiction

In this episode, we break down the truth about DMSO in cell therapy, how it works, why it is used, and what the data really says about its safety. Drawing from a comprehensive review of more than 1100 patients, we explore infusion reactions, dose thresholds, and common misconceptions around DMSO toxicity. We also discuss pharmacokinetics, including the half life of DMSO, urinary elimination, and its metabolism into dimethyl sulfide. Whether you are in biotech, manufacturing, or clinical development, this episode offers a clear and evidence based look at one of the most misunderstood ingredients in regenerative medicine. Featured Article:  Dimethyl Sulfoxide in Cryopreserved Mesenchymal Stromal Cell Therapy Products: Is there a Safety Risk to Patients? (https://doi.org/10.1186/s12967-025-06807-6 [https://doi.org/10.1186/s12967-025-06807-6])

Ep. 25 The Organoid Revolution: Ending Animal Testing with Better Science

What if we could test new drugs and study diseases without using animals? In this episode, we dive into the world of organoids, mini organs grown from human cells that are reshaping biomedical research. We unpack how these tiny living systems mimic real human tissue, offering scientists a more accurate and ethical way to study biology and develop new treatments. From breakthroughs in drug testing to the promise of personalized medicine, this episode explores how organoids are driving a revolution in science that is both smarter and more humane. Featured Article:  Replacing Animal Testing with Stem Cell-Organoids : Advantages and Limitations (https://doi.org/10.1007/s12015-024-10723-5 [https://doi.org/10.1007/s12015-024-10723-5])